MEDXTRACTOR CORP. REPORTS RECORD REVENUES AND NET PROFIT IN Q3 2020
For Immediate Release
Calgary, Alberta – January 9, 2020. MedXtractor Corp. (CSE: MXT) (“MXT” or the “Corporation”) announces net profitable operations for the quarter ended November 30, 2019 and positive cash flow for the nine months ended November 30, 2019. As the Corporation’s fiscal year-end is February, the quarter ended November 30, 2019 is Q3, 2020. The Corporation released of its unaudited interim condensed financial statements and Management’s Discussion and Analysis (“MD&A”) for the three and nine months ended November 30, 2019 that have been filed with Canadian securities regulatory authorities under the Company’s profile on SEDAR at www.sedar.com.
Both Revenues and gross profit have increased every quarter-over-quarter since the Company’s inception and as at November 30, 2019, MXT had working capital of $629,350 including cash of $550,973 as compared to working capital of $235,377 including cash of $143,489 as at February 28, 2019. MXT has no debt.
Mr. Jim Durward, CEO, states “Our record quarter resulted from strict adherence to our low-fixed-cost operating model, a highly targeted marketing effort, the wide spread cannabis legalization movement and increased seasonal demand. Going forward we will seek to increase shareholder value from internal product development, outside product additions, and possibly mergers and acquisitions. Despite the positive nature of our operations, our share price has not escaped the overall depressed state of the entire cannabis complex. With our very low market capitalization, currently less than $2,000,000, I believe that MXT represents one of the best options for ancillary cannabis investors.”
ABOUT MEDXTRACTOR CORP.:
The Corporation is a Calgary-based company that manufactures award-winning, patented, proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. Growing demand is from the premium craft medical cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories. The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the Corporation has installations in multiple countries worldwide. The Corporation owns the US patent, and the Canadian Patent application, on its CO2-based extraction process.
FOR FURTHER INFORMATION, PLEASE CONTACT:
James M. Durward, President and CEO
Telephone: (403) 689-3901
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.